Cargando…
New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide
Diuretics are commonly used in critically ill patients with acute kidney injury (AKI) and fluid overload in intensive care units (ICU), furosemide being the diuretic of choice in more than 90% of the cases. Current evidence shows that other diuretics with distinct mechanisms of action could be used...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479653/ https://www.ncbi.nlm.nih.gov/pubmed/37675009 http://dx.doi.org/10.3389/fneph.2022.879766 |
_version_ | 1785101638700105728 |
---|---|
author | Escudero, Victor Joaquin Mercadal, Jordi Molina-Andújar, Alícia Piñeiro, Gaston J. Cucchiari, David Jacas, Adriana Carramiñana, Albert Poch, Esteban |
author_facet | Escudero, Victor Joaquin Mercadal, Jordi Molina-Andújar, Alícia Piñeiro, Gaston J. Cucchiari, David Jacas, Adriana Carramiñana, Albert Poch, Esteban |
author_sort | Escudero, Victor Joaquin |
collection | PubMed |
description | Diuretics are commonly used in critically ill patients with acute kidney injury (AKI) and fluid overload in intensive care units (ICU), furosemide being the diuretic of choice in more than 90% of the cases. Current evidence shows that other diuretics with distinct mechanisms of action could be used with good results in patients with selected profiles. From acetazolamide to tolvaptan, we will discuss recent studies and highlight how specific diuretic mechanisms could help to manage different ICU problems, such as loop diuretic resistance, hypernatremia, hyponatremia, or metabolic alkalosis. The current review tries to shed some light on the potential use of non-loop diuretics based on patient profile and give recommendations for loop diuretic treatment performance focused on what the intensivist and critical care nephrologist need to know based on the current evidence. |
format | Online Article Text |
id | pubmed-10479653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104796532023-09-06 New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide Escudero, Victor Joaquin Mercadal, Jordi Molina-Andújar, Alícia Piñeiro, Gaston J. Cucchiari, David Jacas, Adriana Carramiñana, Albert Poch, Esteban Front Nephrol Nephrology Diuretics are commonly used in critically ill patients with acute kidney injury (AKI) and fluid overload in intensive care units (ICU), furosemide being the diuretic of choice in more than 90% of the cases. Current evidence shows that other diuretics with distinct mechanisms of action could be used with good results in patients with selected profiles. From acetazolamide to tolvaptan, we will discuss recent studies and highlight how specific diuretic mechanisms could help to manage different ICU problems, such as loop diuretic resistance, hypernatremia, hyponatremia, or metabolic alkalosis. The current review tries to shed some light on the potential use of non-loop diuretics based on patient profile and give recommendations for loop diuretic treatment performance focused on what the intensivist and critical care nephrologist need to know based on the current evidence. Frontiers Media S.A. 2022-07-08 /pmc/articles/PMC10479653/ /pubmed/37675009 http://dx.doi.org/10.3389/fneph.2022.879766 Text en Copyright © 2022 Escudero, Mercadal, Molina-Andújar, Piñeiro, Cucchiari, Jacas, Carramiñana and Poch https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Nephrology Escudero, Victor Joaquin Mercadal, Jordi Molina-Andújar, Alícia Piñeiro, Gaston J. Cucchiari, David Jacas, Adriana Carramiñana, Albert Poch, Esteban New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide |
title | New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide |
title_full | New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide |
title_fullStr | New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide |
title_full_unstemmed | New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide |
title_short | New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide |
title_sort | new insights into diuretic use to treat congestion in the icu: beyond furosemide |
topic | Nephrology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479653/ https://www.ncbi.nlm.nih.gov/pubmed/37675009 http://dx.doi.org/10.3389/fneph.2022.879766 |
work_keys_str_mv | AT escuderovictorjoaquin newinsightsintodiureticusetotreatcongestionintheicubeyondfurosemide AT mercadaljordi newinsightsintodiureticusetotreatcongestionintheicubeyondfurosemide AT molinaandujaralicia newinsightsintodiureticusetotreatcongestionintheicubeyondfurosemide AT pineirogastonj newinsightsintodiureticusetotreatcongestionintheicubeyondfurosemide AT cucchiaridavid newinsightsintodiureticusetotreatcongestionintheicubeyondfurosemide AT jacasadriana newinsightsintodiureticusetotreatcongestionintheicubeyondfurosemide AT carraminanaalbert newinsightsintodiureticusetotreatcongestionintheicubeyondfurosemide AT pochesteban newinsightsintodiureticusetotreatcongestionintheicubeyondfurosemide |